To authorize the President to enter into trade agreements for the reciprocal elimination of duties or other import restrictions with respect to medical goods to contribute to the national security and public health of the United States, and for other purposes.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, To authorize the President to enter into trade agreements for the reciprocal elimination of duties or other import restrictions with respect to medical goods to contribute to the national security and public health of the United States, and for other purposes., changes federal law or congressional policy affecting importers, exporters, and commercial firms. The main policy domain is Trade, Government Operations, Healthcare.
Who Benefits and How
importers, exporters, and commercial firms may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, importers, exporters, and commercial firms may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section H27BC224F05994892A70838C4A8FB3978: 1. Short title This Act may be cited as the Medical Supply Chain Resiliency Act.
- Section HCEF78BFCEA0142AC95D3C9A4589E5AA8: 2. Findings; sense of Congress Congress makes the following findings: The COVID–19 pandemic created significant demand pressures on the global medical supply...
- Section H84633622975D43B3AFCFB6BB91B5F396: 3. Purposes The purposes of this Act are— to improve overall medical supply chain resilience for the United States by establishing a framework to enhance...
- Section HE1A0D11173874BCCABA4440E976199CB: 4. Definitions In this Act: The term appropriate committees of Congress means— the Committee on Finance of the Senate; and the Committee on Ways and Means of...
- Section H3205FFA4956941FA95A454A81B482E36: 5. Authority to enter into trusted trade partner agreements Whenever the President determines, based on the considerations set forth in subsection (b), that...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, To authorize the President to enter into trade agreements for the reciprocal elimination of duties or other import restrictions with respect to medical goods to contribute to the national security and public health of the United States, and for other purposes., changes federal law or congressional policy affecting importers, exporters, and commercial firms.
Key Policy Areas
Trade, Government Operations, Healthcare
Primary Purpose
This bill, To authorize the President to enter into trade agreements for the reciprocal elimination of duties or other import restrictions with respect to medical goods to contribute to the national security and public health of the United States, and for other purposes., changes federal law or congressional policy affecting importers, exporters, and commercial firms.
Policy Domains
Whole bill
Identified Gains
- importers, exporters, and commercial firms
Identified Costs
- federal implementing agencies
- importers, exporters, and commercial firms
Sponsors
Legislative Progress
IntroducedMrs. Steel (for herself and Mr. Schneider) introduced the following …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_commission"
- → The commission identified in the operative section
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology